Stay updated with breaking news from John Sims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
St. John's United Methodist Church, 230 Renee Drive, Baton Rouge, will offer the new GriefShare 4 program from 2 p.m. to 3:30 p.m. starting Aug. 22 and running Tuesdays through
WASHINGTON—Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening—by about four to seven months, researchers reported Monday. Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease—after the recently…
Sims & Blue Ltd, one of Dunedin’s oldest painting and decorating firms, is closing in on training its 100th apprentice. Of the 90-plus trained to...
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening. Patients given monthly infusions of Eli Lilly and Co.'s donanemab declined about four to seven months more slowly than those given dummy infusions in a large study. If U.S. regulators approve, the drug would be only the second Alzheimer's treatment convincingly shown to delay the mind-robbing disease — after rival Leqembi. Both drugs pose a serious safety concern — brain swelling and bleeding. Lilly's data was presented at an Alzheimer's Association internatio...
After seeing Alzheimer's rob many of her older relatives of their memories and independence Lori Weiss, from Oregon, feared she would suffer the same fate following her diagnosis last year.